{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:38Z","timestamp":1707525398352},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,11]]},"DOI":"10.7759\/cureus.48647","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T11:46:26Z","timestamp":1699703186000},"source":"Crossref","is-referenced-by-count":0,"title":["Emergence of Rapid-Onset Ototoxicity Following Three Doses of Vancomycin: A Unique Case Report in the Context of Normal Renal Function and Therapeutic Dosing"],"prefix":"10.7759","author":[{"given":"Yisroel  Y","family":"Grabie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Chain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Xerras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaf A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42 Suppl 1","author":"Rybak MJ","year":"2006","unstructured":"Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006, 42 Suppl 1:S35-9. 10.1086\/491712","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak MJ","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, et al.. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020, 77:835-64. 10.1093\/ajhp\/zxaa036","journal-title":"Am J Health Syst Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652674","article-title":"Ototoxicity of non-aminoglycoside antibiotics","volume":"12","author":"Rybak LP","year":"2021","unstructured":"Rybak LP, Ramkumar V, Mukherjea D. Ototoxicity of non-aminoglycoside antibiotics. Front Neurol. 2021, 12:652674. 10.3389\/fneur.2021.652674","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01088-08","article-title":"Vancomycin ototoxicity: a reevaluation in an era of increasing doses","volume":"53","author":"Forouzesh A","year":"2009","unstructured":"Forouzesh A, Moise PA, Sakoulas G. Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrob Agents Chemother. 2009, 53:483-6. 10.1128\/AAC.01088-08","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.2.235","article-title":"A prospective study of adverse reactions associated with vancomycin therapy","volume":"16","author":"Sorrell T","year":"1985","unstructured":"Sorrell T, Collignon P. A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother. 1985, 16:235-41. 10.1093\/jac\/16.2.235","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224561","article-title":"Long-term vancomycin use had low risk of ototoxicity","volume":"14","author":"Humphrey C","year":"2019","unstructured":"Humphrey C, Veve MP, Walker B, Shorman MA. Long-term vancomycin use had low risk of ototoxicity. PLoS One. 2019, 14:e0224561. 10.1371\/journal.pone.0224561","journal-title":"PLoS One"},{"key":"ref7","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera FR","year":"2015","unstructured":"Bruniera FR, Ferreira FM, Saviolli LR, et al.. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015, 19:694-700.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2980913","article-title":"An unusual case of ototoxicity with use of oral vancomycin","volume":"2018","author":"Gomceli U","year":"2018","unstructured":"Gomceli U, Vangala S, Zeana C, Kelly PJ, Singh M. An unusual case of ototoxicity with use of oral vancomycin. Case Rep Infect Dis. 2018, 2018:2980913. 10.1155\/2018\/2980913","journal-title":"Case Rep Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/lary.1983.93.5.649","article-title":"Ototoxicity of oral neomycin and vancomycin","volume":"93","author":"Kavanagh KT","year":"1983","unstructured":"Kavanagh KT, McCabe BF. Ototoxicity of oral neomycin and vancomycin. Laryngoscope. 1983, 93:649-53. 10.1002\/lary.1983.93.5.649","journal-title":"Laryngoscope"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/138161207779313731","article-title":"Aminoglycoside-induced ototoxicity","volume":"13","author":"Selimoglu E","year":"2007","unstructured":"Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007, 13:119-26. 10.2174\/138161207779313731","journal-title":"Curr Pharm Des"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2014.35744","article-title":"Sudden sensorineural hearing loss in a multiple sclerosis case","volume":"1","author":"Tekin M","year":"2014","unstructured":"Tekin M, Acar GO, Cam OH, Hanege FM. Sudden sensorineural hearing loss in a multiple sclerosis case. North Clin Istanb. 2014, 1:109-13. 10.14744\/nci.2014.35744","journal-title":"North Clin Istanb"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4137\/JCNSD.S14049","article-title":"Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis","volume":"6","author":"Hoepner R","year":"2014","unstructured":"Hoepner R, Faissner S, Salmen A, Gold R, Chan A. Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis. J Cent Nerv Syst Dis. 2014, 6:41-9. 10.4137\/JCNSD.S14049","journal-title":"J Cent Nerv Syst Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187695-emergence-of-rapid-onset-ototoxicity-following-three-doses-of-vancomycin-a-unique-case-report-in-the-context-of-normal-renal-function-and-therapeutic-dosing","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:57Z","timestamp":1707509397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187695-emergence-of-rapid-onset-ototoxicity-following-three-doses-of-vancomycin-a-unique-case-report-in-the-context-of-normal-renal-function-and-therapeutic-dosing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.48647","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,11]]}}}